D-Wave Quantum shares fell 2.8% on Friday as the broader technology tape weakened, with quantum-computing peers IonQ and Rigetti also coming under selling pressure and losses in AI-oriented names weighing on US markets. The move raises a question that product announcements cannot answer on their own: how durable is the growth story when investors start judging the company on current business results rather than future potential?
Quantum computing and artificial intelligence are not the same business, yet their stocks ran into the same headwind. For D-Wave, that backdrop meets an awkward mix — genuine technical progress, orders that swing sharply from quarter to quarter, and added legal exposure. Separating those layers is essential; not every positive product headline translates into commercial success.
A solver that got eight times faster
Take the November 4 announcement. D-Wave unveiled improvements to its hybrid Stride solver, which in key benchmark tests found better solutions in 15 seconds than the previous version managed in 120 seconds, according to the company. Alongside it, D-Wave launched a training program for applied quantum optimization.
That is a tangible technical claim — an improvement inside an existing product rather than a vague vision of the future. But it answers a different question than a quarterly filing does. A more powerful tool is, first and foremost, product progress. Whether it produces dependable revenue has yet to show up in the business.
Faster results can make an application more attractive. They do not automatically convert into predictable quarterly sales. For that, orders, their execution and actually booked revenue are what count.
Revenue up, bookings down
The third-quarter 2026 figures reported on Tuesday capture exactly that tension. Revenue rose 21% year on year to $4.5 million — growth, but no answer to the question of a steady business trajectory. On the order side the picture inverted: quarterly bookings fell 19% year on year to $1.9 million.
Revenue and fresh bookings thus moved in opposite directions during the quarter. That is the crux. What is on trial is not only technical capability but the predictability of its commercial use.
Over nine months, D-Wave reported bookings of $37.4 million, up 611%. It also put remaining performance obligations at $38.3 million. Those longer-range figures provide a counterweight to the weaker quarterly intake, though they hardly justify ignoring short-term volatility. Analysts who cut price targets on Wednesday cited, among other things, hard-to-forecast revenue timing, according to media reports; others tied their revisions to lower valuations across the peer group.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Customers putting the technology to work
Commercial traction offers a more concrete yardstick than the promise of a vast quantum market someday. NTT DOCOMO has now put a second production application built on D-Wave’s hybrid quantum technology into operation, the company said Tuesday. The repetition matters: a further live deployment at the same customer points to practical fit, provided continued use follows.
The same day brought word that an Advantage2 annealing quantum computer is on its way to Lombardy, to be installed at Villa Saporiti in support of the Q-Alliance. The commercial test there lies in the shift from delivery to the intended use. In parallel, D-Wave opened a beta program for its gate-model quantum computing simulator — an expansion of its technological reach that gains weight for investors only if testing yields robust applications. The common thread is execution: technical possibilities must become usable offerings.
Milestone-linked public funding
Financing belongs in the same frame. The public funds come with strings attached — milestones and further conditions. That structure makes progress measurable, since the potential financial headroom depends on meeting specific requirements. The agreed access is a positive for D-Wave as long as it satisfies the terms, so operational advances and the funding outlook should be weighed together.
How demanding the commercial path remains is clear from Tuesday’s results. Alongside the $4.5 million in third-quarter revenue, D-Wave posted a net loss of $48.197 million. Commercialization therefore carries extra weight: live applications and shipped machines are the tangible markers against which future business development can be judged.
Legal risk on the ledger
One more item belongs in any assessment. A securities suit contains allegations of misleading statements between February 27 and August 25. These are accusations, not established violations. Pomerantz named December 15, 2026 as the deadline for motions to be appointed lead plaintiff.
The right stance, then, is neither unbridled tech enthusiasm nor a blanket write-down of an entire sector. D-Wave must turn technical improvements and its existing bookings into verifiable business results. The weak technology backdrop sharpens the scrutiny. What matters in the end is whether progress becomes reliability — and whether the second DOCOMO application, the Italian installation and the funding conditions become recurring demand rather than one-off headlines.
Ad
D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from November 15 delivers the answer:
The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 15.
D-Wave Quantum: Buy or sell? Read more here...
